Adult Acute Lymphoblastic Leukemia — Trials

Adult Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

249 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 44
Recruiting: 21
Ph III recruiting: 1
Growth YoY: —
Industry share: 7%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (37)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02112916	Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma	active not recruiting	Phase 3	847	National Cancer Institute (NCI)NIH	4	Jul 29, 2026	clinicaltrials
NCT04722848	Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL	active not recruiting	Phase 3	236	Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER